A

Annovis Bio (ANVS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Annovis Bio (ANVS)

Annovis Bio, Inc. operates as a biotechnology company. The Company develops drugs for alzheimer's and parkinson's disease, including the orphan indication dementia and alzheimer's in down syndrome. Annovis Bio serves customers in the State of Pennsyl... Read more

  • USD12.90
  • USD13.96
  • USD12.73
  • USD23.91
  • 4.30%
  • --
  • 14.00
  • 31.50k
  • 105M
  • 8.39
  • -4.00%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.